Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol vs Sevoflurane in Renal Cancer Surgery
NCT03514550Phase 4Completed
- Sponsor
- E. Meshalkin National Medical Research Centre
- Start
- May 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of propofol in renal cell carcinoma (RCC), sponsored by E. Meshalkin National Medical Research Centre. Started May 2018; status: completed.
02
Drugs
propofol
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT03514550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03514550.